Hirokawa, Yumiko <br/><br/>
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).  [electronic resource] 

 -  Cancer letters  Jan 2007 
 - 242-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0304-3835 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2006.01.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Depsipeptides--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme Inhibitors--administration & dosage<br/>Humans<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Molecular Structure<br/>Neurofibromin 1--deficiency<br/>Nitriles--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Quaternary Ammonium Compounds--administration & dosage<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays--methods<br/>src-Family Kinases--antagonists & inhibitors